Dow Up 0.03% Nasdaq Down 0.02%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.93 Up 0.04(0.68%) 2:57PM EDT - Nasdaq Real Time Price
Prev Close:5.89
Open:5.88
Bid:6.02 x 4500
Ask:6.03 x 12000
1y Target Est:9.75
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.82 - 6.12
52wk Range:4.60 - 7.82
Volume:5,032,446
Avg Vol (3m):3,514,360
Market Cap:726.66M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 0.68%726.66M
ABTDown 0.55%64.00B
GSKUp 0.73%116.76B
RHHBYUp 0.27%249.44B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):210.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback